Product Specific References | - Ksander BR, Rubsamen PE, Olsen KR, Cousins SW, Streilein JW. 1991 Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma. Invest Ophthalmol Vis Sci. 32(13):3198-208.
- Chen PW, Murray TG, Salgaller ML, Ksander BR (1997) Expression of MAGE genes in ocular melanoma cell lines. J Immunother 20: 265275.
- de Waard-Siebinga I, Creyghton WM, Kool J, Jager MJ. 1995 Effects of interferon alfa and gamma on human uveal melanoma cells in vitro. Br J Ophthalmol. 79(9):847-55.
- Griewank KG, Yu X, Khalili J, Sozen MM, Stempke-Hale K, Bernatchez C, Wardell S, Bastian BC, Woodman SE. Genetic and molecular characterization of uveal melanoma cell lines. Pigment Cell Melanoma Res. 2012 Mar;25(2):182-7.
- Ma D, Luyten GP, Luider TM, Jager MJ, Niederkorn JY. 1996 Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model. Invest Ophthalmol Vis Sci. 37(11):2293-301.
- Ren DH, Mayhew E, Hay C, Li H, Alizadeh H, Niederkorn JY 2004 Uveal melanoma expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors and susceptibility to TRAIL-induced apoptosis. Invest Ophthalmol Vis Sci. 45(4):1162-8.
- Abdel-Rahman MH, Boru G, Massengill J, Salem MM, Davidorf FH 2010 MET oncogene inhibition as a potential target of therapy for uveal melanomas. Invest Ophthalmol Vis Sci. 51(7):3333-9.
|